Clinical trial NCT01162733: Loading Vancomycin Doses in the Emergency Department
Official title: A Randomized Prospective Study of Vancomycin Dosing in the Emergency Department: Will a Loading Dose of 30mg/kg Lead to a More Rapid Attainment of Therapeutic Levels?
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Infectious Disease
Keywords: Vancomycin
Therapeutic Levels
Infectious Disease
Recommendations
Lead sponsor: Christiana Care Health Services
Sponsor class: OTHER
First posted: 2010-07-15
Enrollment: 99
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: In 2008, our ED administered an average of 245 doses of vancomycin per month. Currently there is no consistency in the ED practice in regards to vancomycin dosing. In 2009, the IDSA put forth new recommendations for vancomycin dosing in order to achieve therapeutic levels more rapidly. It has been hypothesized that if therapeutic levels are reached more rapidly then patients will in turn have better clinical outcomes and that the development of resistant organisms will be decreased. Methicillin resistant Staphylococcus aureus (MRSA) has emerged as one of the most deadly pathogens that are currently plaguing our patient population. Vancomycin is one of only a few antibiotics that are effective for treating MRSA. It is imperative that the ED physicians consistently and correctly dose vancomycin in order to give the patients the best chance to fight infection while helping to prevent further resistance in this already highly resistant organism. It is believed this study will reveal that the new dosing recommendations by the IDSA will lead to the achievement of therapeutic levels more rapidly. This information will in turn help to convince ED physicians that a change in current clinical practice is warranted and ultimately lead to better clinically outcomes for the patients.

Detailed description: Recently, the Infectious Disease Society of America (IDSA) has released new dosing recommendations for intravenous (IV) vancomycin. These new recommendations suggest administering an initial dose of 25-30 mg/kg of vancomycin as opposed to 10-15 mg/kg which is more traditionally done. Currently in the Emergency Department (ED) some practitioners are using the new IDSA dosing recommendations for vancomycin, while other practitioners have not changed their clinical practice. There is currently little data available to suggest that implementing these new vancomycin dosing regimens in the ED will achieve therapeutic vancomycin levels more rapidly than our traditional dosing practice.

Eligibility criteria: Inclusion Criteria:

* At least 18 years of age
* Treated in Christiana Emergency Department
* Receiving Vancomycin for an infection or presumed infection
* Being admitted to Christiana Hospital
* Planned continued use of Vancomycin after admission.

Exclusion Criteria:

* Less than 18 years of age
* Weight greater than 120 kg.
* Concurrent use of aminoglycosides or acyclovir
* Sepsis patients being admitted to ICU with presumed diagnosis of pneumonia
* Patients currently undergoing dialysis
* Pregnant or breast feeding
* No plan to continue Vancomycin after admission.
* Creatinine clearance less than 50ml/min.

Primary outcomes:
measure: Percentage of Participants First Achieving Therapeutic Levels at 36 Hours
timeFrame: 36 hours
measure: Percentage of Participants First Achieving Therapeutic Levels at 12 Hours
timeFrame: 12 hours
Secondary outcomes:
Other outcomes:
Locations:
city: Newark
country: United States
facility: Chrisitana Care Health System-Christiana Hospital
state: Delaware
Study officials:
affiliation: Christiana Care Health Services
name: Brian Levine, MD
role: PRINCIPAL_INVESTIGATOR
References: